Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days
Clinical trial NCT07614958 · RECRUITING
Trial details
- NCT number
- NCT07614958
- Sponsor
- A. Menarini International Licensing S.A.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-06
- Primary completion
- 2027-01-01
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.